Cargando…
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment
BACKGROUND: The renal function of individuals is one of the reasons for the variations in therapeutic response to various drugs. Patients with renal impairment are often exposed to drug toxicity, even with drugs that are usually eliminated by hepatic metabolism. Previous study has reported an increa...
Autores principales: | Kim, Andrew HyoungJin, Yoon, Sumin, Lee, Yujin, Lee, Jieon, Bae, Eunjin, Lee, Hajeong, Kim, Dong Ki, Lee, SeungHwan, Yu, Kyung-sang, Jang, In-Jin, Cho, Joo-Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306325/ https://www.ncbi.nlm.nih.gov/pubmed/30595680 http://dx.doi.org/10.3346/jkms.2018.33.e298 |
Ejemplares similares
-
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase
por: Kang, Jihyun, et al.
Publicado: (2021) -
Impact of Vancomycin‐Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin
por: Sunwoo, Jung, et al.
Publicado: (2020) -
Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians
por: Lee, Jieon, et al.
Publicado: (2018) -
Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men
por: Kim, Andrew HyoungJin, et al.
Publicado: (2021) -
A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2017)